Venous thrombosis risk assessment in medical inpatients: the medical inpatients and thrombosis (MITH) study

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2013-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jth.12147PMID 23336744
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012cited by this paper
• Preventing Venous Thromboembolism in Hospitalized Patients: Recommendations From the American College of Physicians

  2011cited by this paper
• Venous Thromboembolism Prophylaxis in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians

  2011cited by this paper
• Venous Thromboembolism Prophylaxis in Hospitalized Medical Patients and Those With Stroke: A Background Review for an American College of Physicians Clinical Practice Guideline

  2011cited by this paper
• Risk factor model to predict venous thromboembolism in hospitalized medical patients.

  2011cited by this paper
• Low-molecular-weight heparin and mortality in acutely ill medical patients.

  2011cited by this paper
• Predictive and associative models to identify hospitalized medical patients at risk for VTE.

  2011cited by this paper
• Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients.

  2011cited by this paper
• Individual patient data meta‐analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patients

  2011cited by this paper
• A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score

  2010cited by this paper
• Development and validation of a predictive model for chemotherapy-associated thrombosis.

  2008cited by this paper
• Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients

  2007cited by this paper
• Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.

  2007cited by this paper
• Venous thromboembolism (VTE) in Europe

  2007cited by this paper
• Thromboprophylaxis in medically ill patients at risk for venous thromboembolism.

  2006cited by this paper
• Handbook of Epidemiology

  2006cited by this paper
• Electronic alerts to prevent venous thromboembolism among hospitalized patients.

  2005cited by this paper
• Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study

  2005cited by this paper
• Risk Factors for Deep Vein Thrombosis in Inpatients Aged 65 and Older: A Case‐Control Multicenter Study

  2004cited by this paper
• Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.

  2004cited by this paper
• Randomized, Placebo-Controlled Trial of Dalteparin for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

  2004cited by this paper
• Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score

  2004cited by this paper
• Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology.

  2002cited by this paper
• Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.

  2002cited by this paper
• Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).

  2002cited by this paper
• Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

  2001cited by this paper
• Incidence of venous thromboembolism in hospitalized patients vs community residents.

  2001cited by this paper
• Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score.

  2000cited by this paper
• Prevention of Venous Thromboembolism in Internal Medicine with Unfractionated or Low-molecular-weight Heparins: A Meta-analysis of Randomised Clinical Trials

  2000cited by this paper
• A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.

  1999cited by this paper
• Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.

  1998cited by this paper
• Venous thromboembolism prophylaxis and risk assessment in medical patients.

  1991cited by this paper
• Sampling techniques.

  1971cited by this paper

• The effect of prophylactic anticoagulation on major bleeding events in hospitalized patients with chronic kidney disease and lower limb fractures: a phase 2, randomized, double-blind, controlled trial

  2025influential citation
• Venous Thromboembolism Risk Assessment and Prophylaxis: An Audit-Based Study

  2025cites this paper
• Development and Validation of Risk Models for Hospital-Acquired Bleeding in Medical Inpatients: The Medical Inpatients Thrombosis and Hemostasis (MITH) Study.

  2025cites this paper
• Trends of hospital-acquired lower limb deep venous thrombosis in an academic medical center in China from 2007 to 2021.

  2025cites this paper
• A composite risk assessment model for venous thromboembolism

  2024cites this paper
• Association Between White Blood Cell Counts at Diagnosis and Clinical Outcomes in Venous Thromboembolism　- From the COMMAND VTE Registry-2.

  2024cites this paper
• Association between inflammatory biomarkers and venous thromboembolism: a systematic review and meta-analysis

  2023cites this paper
• Development and validation of machine learning models for postoperative venous thromboembolism prediction in colorectal cancer inpatients: a retrospective study

  2023cites this paper
• Development and Validation of a Risk Model for Hospital-Acquired Venous Thrombosis: The Medical Inpatients Thrombosis and Hemostasis (MITH) Study.

  2023cites this paper
• Simple yet (more?) effective. Venous thromboembolism risk assessment model for germ cell tumour patients receiving first‐line chemotherapy

  2023cites this paper
• Development of a computable phenotype using electronic health records for venous thromboembolism in medical inpatients: the Medical Inpatient Thrombosis and Hemostasis study

  2023cites this paper
• Venous thrombosis risk during and after medical and surgical hospitalizations: The medical inpatient thrombosis and hemostasis (MITH) study

  2022cites this paper
• The Use of Risk Scores for Thromboprophylaxis in Medically Ill Patients—Rationale and Design of the RICO trial

  2022cites this paper
• Current use of D-dimer for the exclusion of venous thrombosis in hospitalized patients

  2022cites this paper
• Assessment of Postoperative Outcomes of Spine Fusion Patients With History of Cardiac Disease

  2022cites this paper
• A retrospective cohort study of disease-related risk factors for central venous catheter-related symptomatic thrombosis in intensive care unit inpatients

  2021cites this paper
• Post‐discharge thrombosis and bleeding in medical patients: A novel risk score derived from ubiquitous biomarkers

  2021cites this paper
• Predicting postdischarge hospital‐associated venous thromboembolism among medical patients using a validated mortality risk score derived from common biomarkers

  2020cites this paper
• Prognostic factors for VTE and Bleeding in Hospitalized Medical Patients: a systematic review and meta-analysis.

  2020cites this paper
• Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment.

  2020cites this paper
• Development of a Risk Model for Pediatric Hospital-Acquired Thrombosis: A Report from the CHAT Consortium.

  2020cites this paper
• Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews.

  2020cites this paper
• Prescribing patterns and outcomes of venous thromboembolism prophylaxis in hospitalized medical and cancer patients: Observations from the Ottawa Hospital.

  2020cites this paper
• Disease-Related Risk Factors for CVC-Related Symptomatic Thrombosis in Surgical ICU Inpatients

  2020cites this paper
• [Importance of thromboprophylaxis in hospitalized non-surgical patients].

  2019cites this paper
• Validation of risk assessment models for venous thrombosis in hospitalized medical patients

  2019cites this paper
• Risk factors for cancer‐associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE‐PACC) study

  2019cites this paper
• Black Patients Experience Highest Rates of Cancer-associated Venous Thromboembolism

  2019cites this paper
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.

  2018cites this paper
• Atrial fibrillation is related to lower incidence of deep venous thrombosis in patients with pulmonary embolism.

  2018cites this paper
• Scoring Systems for Estimating Risk of Venous Thromboembolism in Hospitalized Medical Patients

  2017cites this paper
• The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice.

  2016cites this paper
• The epidemiology of venous thromboembolism

  2016cites this paper
• Central venous catheters and upper extremity deep vein thrombosis in medical inpatients: the Medical Inpatients and Thrombosis (MITH) Study

  2015cites this paper
• Epidemiology of venous thromboembolism

  2015cites this paper
• [The PROMET study: Prophylaxis for venous thromboembolic disease in at-risk patients hospitalized in Algeria].

  2015cites this paper
• Inflammation in venous thromboembolism: Cause or consequence?

  2015cites this paper
• Venous thrombosis and cancer: from mouse models to clinical trials

  2015cites this paper
• Racial and Regional Differences in Venous Thromboembolism in the United States in 3 Cohorts

  2014cites this paper
• Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort

  2014cites this paper
• Identification of APOH polymorphisms as common genetic risk factors for venous thrombosis in the Chinese population

  2014cites this paper
• Investigación de la trombofilia venosa. Presente y futuro

  2014cites this paper
• Thromboprophylaxis for medical patients with cancer: what do the guidelines say?

  2014cites this paper
• Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.

  2014cites this paper
• Racial and Regional Differences in Venous Thromboembolism in the United States in Three Cohorts

  2014cites this paper
• Optimization of the diagnostic management of clinically suspected pulmonary embolism in hospitalized patients

  2014influential citation
• Imaging Characteristics of Ischemic Strokes Related to Patent Foramen Ovale

  2013cites this paper
• Systematic Review of Barriers and Facilitators to Venous Thromboembolism Clinical Practice Guideline Compliance by Healthcare Professionals in Acute Care

  2013cites this paper
• Patient selection for thromboprophylaxis in medical inpatients

  2013cites this paper